PMID- 23250662
OWN - NLM
STAT- MEDLINE
DCOM- 20130517
LR  - 20211021
IS  - 1534-3170 (Electronic)
IS  - 1523-3782 (Linking)
VI  - 15
IP  - 1
DP  - 2013 Jan
TI  - The prognostic value of late gadolinium enhancement CMR in nonischemic 
      cardiomyopathies.
PG  - 326
LID - 10.1007/s11886-012-0326-2 [doi]
AB  - Cardiovascular magnetic resonance (CMR) is a valuable clinical tool in everyday 
      practice providing additional information to echocardiography. The late 
      gadolinium enhancement (LGE) technique is now part of nearly every CMR protocol 
      and enables in-vivo tissue characterization in ischemic (identification of 
      scaring due to infarction) and many nonischemic cardiomyopathies (identification 
      of regional or patchy fibrosis or infiltration). This review presents the 
      evolving prognostic evidence base of LGE-CMR with a particular focus on 
      nonischemic cardiomyopathies. Novel methods to assess diffuse myocardial fibrosis 
      such as pre- and post-contrast T1-mapping are also discussed.
FAU - Karamitsos, Theodoros D
AU  - Karamitsos TD
AD  - Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, UK. 
      theo.karamitsos@cardiov.ox.ac.uk
FAU - Neubauer, Stefan
AU  - Neubauer S
LA  - eng
GR  - 090532/Wellcome Trust/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
PL  - United States
TA  - Curr Cardiol Rep
JT  - Current cardiology reports
JID - 100888969
RN  - 0 (Contrast Media)
RN  - AU0V1LM3JT (Gadolinium)
SB  - IM
MH  - Cardiomyopathies/*diagnosis
MH  - Contrast Media
MH  - Fibrosis
MH  - Gadolinium
MH  - Humans
MH  - Image Enhancement/methods
MH  - Magnetic Resonance Angiography/methods
MH  - Myocardium/pathology
MH  - Prognosis
EDAT- 2012/12/20 06:00
MHDA- 2013/05/18 06:00
CRDT- 2012/12/20 06:00
PHST- 2012/12/20 06:00 [entrez]
PHST- 2012/12/20 06:00 [pubmed]
PHST- 2013/05/18 06:00 [medline]
AID - 10.1007/s11886-012-0326-2 [doi]
PST - ppublish
SO  - Curr Cardiol Rep. 2013 Jan;15(1):326. doi: 10.1007/s11886-012-0326-2.